We are live on ! Find out more
CELG

Celgene Corp
CELG

Delisted

CELG was delisted on the 20th of November, 2019.

1,245 hedge funds and large institutions have $56.9B invested in Celgene Corp in 2019 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 350 increasing their positions, 572 reducing their positions, and 106 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 109127 (+18)

12% more capital invested

Capital invested by funds: $51.1B → $56.9B (+$5.88B)

3% less funds holding

Funds holding: 1,2871,245 (-42)

31% less first-time investments, than exits

New positions opened: 73 | Existing positions closed: 106

39% less repeat investments, than reductions

Existing positions increased: 350 | Existing positions reduced: 572

59% less call options, than puts

Call options by funds: $796M | Put options by funds: $1.95B

Holders
1,245
Holders Change
-42
Holders Change %
-3.26%
% of All Funds
27.3%
Holding in Top 10
127
Holding in Top 10 Change
+18
Holding in Top 10 Change %
+16.51%
% of All Funds
2.79%
New
73
Increased
350
Reduced
572
Closed
106
Calls
$796M
Puts
$1.95B
Net Calls
-$1.15B
Net Calls Change
-$98.3M
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$460M +$90.5M +952,261 +26%
N
27
Nuveen
North Carolina
$421M -$22.5M -237,101 -5%
Legal & General Group
28
Legal & General Group
United Kingdom
$415M -$771K -8,115 -0.2%
Janus Henderson Group
29
Janus Henderson Group
United Kingdom
$415M -$82.7M -870,678 -17%
Millennium Management
30
Millennium Management
New York
$414M +$50M +526,102 +14%
Barclays
31
Barclays
United Kingdom
$411M +$29.5M +310,027 +8%
Bank of America
32
Bank of America
North Carolina
$405M +$26.1M +274,613 +7%
TAL
33
TIG Advisors LLC
New York
$388M +$30.4M +320,177 +9%
SC
34
Sculptor Capital
New York
$329M +$87.5M +921,198 +38%
Charles Schwab
35
Charles Schwab
California
$323M +$6.64M +69,897 +2%
TCA
36
Taconic Capital Advisors
New York
$319M +$32.5M +342,333 +12%
RL
37
Ruffer LLP
United Kingdom
$318M +$8.38M +88,241 +3%
PC
38
Paulson & Co
New York
$317M -$14.8M -155,322 -5%
CC
39
Carlson Capital
Texas
$306M +$18.2M +191,566 +7%
UBS AM
40
UBS AM
Illinois
$293M -$19.9M -208,959 -7%
Sumitomo Mitsui Trust Group
41
Sumitomo Mitsui Trust Group
Japan
$289M +$432K +4,542 +0.2%
Deutsche Bank
42
Deutsche Bank
Germany
$273M -$112M -1,181,327 -30%
SGCM
43
Sand Grove Capital Management
United Kingdom
$256M +$9.4M +98,933 +4%
BGIM
44
Boussard & Gavaudan Investment Management
United Kingdom
$253M +$27.9M +294,010 +13%
OP
45
Omni Partners
United Kingdom
$243M +$57.4M +603,610 +33%
YCMGA
46
York Capital Management Global Advisors
New York
$241M -$14.9M -156,982 -6%
Swiss National Bank
47
Swiss National Bank
Switzerland
$231M +$3.81M +40,128 +2%
PPA
48
Parametric Portfolio Associates
Washington
$228M +$5.55M +58,398 +3%
Assenagon Asset Management
49
Assenagon Asset Management
Luxembourg
$224M -$14M -147,055 -6%
N
50
Natixis
France
$222M +$133M +1,400,844 +168%

CELG Hedge Fund Activity: Q3 2019 in Review

1,245 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q3 2019, worth a combined $56.9B — up 12% from $51.1B a quarter earlier.

Sellers outnumbered buyers: 106 funds closed out of CELG and 73 opened new positions — a net loss of 33 holders — while 572 trimmed existing stakes and 350 added.

The largest buyer was HBK Investments, opening a new position worth an estimated $1.5B. The largest seller was Fidelity Investments, cutting an estimated $377M.

  • 1,245 institutional investors held Celgene Corp (CELG) as of Q3 2019, down from 1,287 in Q2 2019.
  • Funds reported $56.9B of Celgene Corp stock for Q3 2019, up 12% quarter-over-quarter.
  • 73 funds opened new Celgene Corp positions in Q3 2019 and 106 closed out, a net change of -33 holders.
  • The largest Celgene Corp buyer in Q3 2019 was HBK Investments, an estimated $1.5B added.
  • The largest Celgene Corp seller in Q3 2019 was Fidelity Investments, an estimated $377M sold.

Based on aggregated 13F filings for Q3 2019.